Related Experiment Video
Updated: Feb 23, 2026

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
1.3K
Development and validation of a multivariate predictive model for rheumatoid arthritis mortality using a machine
José M Lezcano-Valverde1, Fernando Salazar2, Leticia León1
1Rheumatology Department, Hospital Clínical San Carlos, and IdISSC, Madríd, Spain.
Scientific Reports
|September 2, 2017
Summary
Researchers developed a rheumatoid arthritis (RA) mortality prediction model using machine learning. Key predictors include age at diagnosis, erythrocyte sedimentation rate, and hospital admissions, aiding risk stratification.
Area of Science:
- Rheumatology
- Biostatistics
- Machine Learning
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease associated with increased mortality.
- Accurate prediction of RA mortality is crucial for patient management and resource allocation.
Purpose of the Study:
- To develop and validate a machine learning-based clinical prediction model for rheumatoid arthritis mortality.
- To identify key demographic and clinical predictors of RA mortality.
Main Methods:
- Utilized Random Survival Forests (RSF), a machine learning technique, for model development.
- Trained the model on the Hospital Clínico San Carlos RA Cohort (HCSC-RAC) and validated it on the Hospital Universitario de La Princesa Early Arthritis Register Longitudinal study (PEARL).
- Included demographic and clinical variables from the first two years post-diagnosis.
Main Results:
- Age at diagnosis, median erythrocyte sedimentation rate, and number of hospital admissions were identified as significant predictors.
- The model achieved prediction errors of 0.187 (training) and 0.233 (validation).
- Five distinct mortality risk groups were identified, with time-dependent sensitivity and specificity ranging from 0.43-0.80 in the validation cohort.
Conclusions:
- A robust clinical prediction model for RA mortality was successfully developed and validated using RSF.
- The model demonstrates potential for identifying patients at higher risk of mortality.
- Further external validation is recommended to confirm the model's generalizability.
